Y Ozawa
Overview
Explore the profile of Y Ozawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
529
Citations
2526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denewar F, Urano M, Ozawa Y, Suzuki K, Ito T, Kobayashi T, et al.
Clin Radiol
. 2022 Jan;
77(3):e231-e240.
PMID: 35000763
Aim: To evaluate the feasibility and image quality of the double rule-out (DRO) technique using 128-row multidetector computed tomography (CT) for simultaneous evaluation of the aorta and coronary arteries in...
2.
Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, Ozawa Y, et al.
Clin Exp Immunol
. 2020 Nov;
203(3):366-374.
PMID: 33184844
Myasthenia gravis (MG) is characterized by muscle weakness and fatigue caused by the presence of autoantibodies against the acetylcholine receptor (AChR) or the muscle-specific tyrosine kinase (MuSK). Activated T, B...
3.
Ozawa Y, Uzawa A, Yasuda M, Kojima Y, Oda F, Himuro K, et al.
Eur J Neurol
. 2020 Sep;
28(1):314-322.
PMID: 32889770
Objective: To investigate changes in serum complements and their regulators in the pathogenesis of myasthenia gravis (MG). Methods: Forty-four patients with acetylcholine receptor antibody-positive MG, as well as 20 patients...
4.
Uzawa A, Kojima Y, Ozawa Y, Yasuda M, Onishi Y, Akamine H, et al.
Clin Exp Immunol
. 2020 Jul;
202(3):321-324.
PMID: 32706905
Myasthenia gravis (MG) is an autoantibody-mediated inflammatory disease of the neuromuscular junction. Biomarkers indicating disease activity in MG are warranted. Recently, the soluble urokinase plasminogen activator receptor (suPAR) has been...
5.
Uzawa A, Kanai T, Oda F, Ozawa Y, Yasuda M, Kawaguchi N, et al.
Eur J Neurol
. 2019 Jul;
27(1):175-180.
PMID: 31347231
Background And Purpose: Thymectomy is an effective treatment for myasthenia gravis (MG) with anti-acetylcholine receptor (AChR) antibodies. We rarely encounter patients who develop MG after surgery for thymic tumors. This...
6.
Nishida Y, Takahashi Y, Kanai T, Nose Y, Ishibashi S, Sanjo N, et al.
Eur J Neurol
. 2019 Jul;
27(1):100-104.
PMID: 31309642
Background And Purpose: Tapering immunosuppressants is desirable in patients with well-controlled myasthenia gravis (MG). However, the association between tapering of calcineurin inhibitor dosage and reduction-associated exacerbation is not known. The...
7.
Fujishima F, Taniyama Y, Nakamura Y, Okamoto H, Ozawa Y, Ito K, et al.
Dis Esophagus
. 2018 Jan;
31(7).
PMID: 29346536
In esophageal squamous cell carcinoma (ESCC) patients who are treated with chemoradiotherapy (CRT), identification of the presence or absence of residual or recurrent carcinoma is usually pivotal in their clinical...
8.
Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, et al.
Bone Marrow Transplant
. 2017 Jul;
52(10):1390-1398.
PMID: 28714944
HLA 1-locus-mismatched unrelated donors (1MMUD) have been used in allogeneic hematopoietic stem cell transplantation (allo-HCT) for patients who lack an HLA-matched donor. We retrospectively analyzed 3313 patients with acute leukemia...
9.
Kawashima N, Terakura S, Nishiwaki S, Koyama D, Ozawa Y, Ito M, et al.
Bone Marrow Transplant
. 2017 Apr;
52(8):1164-1170.
PMID: 28368374
Graft failure (GF) remains an obstacle to survival after allogeneic hematopoietic stem cell transplantation. However, differentiating GF from delayed engraftment (DE) can be difficult. Host CD8 lymphocytes have been reported...
10.
Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H, Kobayashi N, et al.
Bone Marrow Transplant
. 2017 Jan;
52(6):818-824.
PMID: 28112749
Clinical efficacy of allogeneic hematopoietic cell transplantation (HCT) using reduced-intensity conditioning (RIC) for younger patients remains unclear. We therefore performed a retrospective registry-based study to evaluate outcomes for patients with...